Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 14, Issue 5, 1996, Pages 1642-1648

  Greco, F A ^a   Stroup, S L ^a   Gray, J R ^a   Hainsworth, J D ^a  

^a Sarah Cannon Minnie Pearl Cancer C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; ESOPHAGITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0029911659     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.5.1642     Document Type: Article

References (21)

1. Mattson K, Holsti LR, Holsti P, et al: Inoperable non-small cell lung cancer: Radiation with or without chemotherapy. Eur J Cancer Clin Oncol 24:477-482, 1988
2. Morton RF, Jett JR, McGinnis WL, et al: Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med 115:681-686, 1991
3. Trovo MG, Minatel EM, Franchin G, et al: Radiotherapy versus radiotherapy enhanced by cisplatin stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 24:11-15, 1992
4. Dillman RO, Seagren SL, Propert KJ, et al: A randomized trial of induction chemotherapy plus high dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 323:940-945, 1990
5. Dillman RO, Seagren SL, Herndon J, et al: Randomized trial of induction chemotherapy plus radiation therapy vs radiation therapy alone in stage III non-small cell lung cancer: Five year follow-up of CALGB. Proc Am Soc Clin Oncol 12:329, 1993 (abstr)
6. LeChevalier T, Arriagada R, Quoix E, et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83:417-423, 1991
7. Schaake-Koning C, vandenBogaert W, Dalesio O, et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 326:524-530, 1992
8. Sause WT, Scott C, Taylor S, et al: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trail in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 87:198-205, 1995
9. Hainsworth JD, Thompson DS, Greco FA: Paclitaxel by 1-hour infusion: An active drug in metastatic non-small-cell lung cancer. J Clin Oncol 13:1609-1614, 1995
10. Murphy WK, Fossella FV, Winn RJ, et al: Phase II study of Taxol in patients with untreated advanced non-small cell lung cancer. J Natl Cancer Inst 85:384-388, 1993
11. Chang AY, Kim K, Glick J, et al: Phase II study of Taxol, merbarone and piroxantrone in stage IV non-small cell lung cancer. The Eastern Cooperative Oncology Group results. J Natl Cancer Inst 85:388-394, 1993
12. Strauss GM, Langer MP, Elias AD, et al: Multimodality treatment of stage IIIA non-small-cell lung carcinoma: A critical review of the literature and strategies for future research. J Clin Oncol 10:829-838, 1992
13. Hazuka MB, Crowley JJ, Bunn PA, et al: Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: Results of a phase II Southwest Oncology Group study. J Clin Oncol 12:1814-1820, 1994
14. Tischler RB, Schiff PB, Geard GR: Taxol: A novel radiation sensitizer. In J Radiat Oncol Biol Phys 22:613-617, 1992
15. Hainsworth JD, Greco FA: Paclitaxel administered by one hour infusion: Preliminary results of a phase I/II trial comparing two schedules. Cancer 74:1377-1382, 1994
16. Ihde DC, Minna JD: Non-small cell lung cancer. Part I: Biology, diagnosis, and staging. Curr Probl Cancer 15:63-104, 1991
17. Curran WJ Jr, Stafford PM: Lack of apparent difference in outcome between clinically stage IIIA and IIIB non-small-cell lung cancer treated with radiation therapy. J Clin Oncol 8:409-415, 1990
18. Roswit B, Patno ME, Rapp R, et al: The survival of patients with inoperable lung cancer: A large-scale randomized study of radiation therapy versus placebo. Radiology 90:688-697, 1968
19. Johnson DH, Einhorn LH, Bartolucci A, et al: Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med 113:33-38, 1990
20. Roth JA, Fossella F, Komaki R, et al: A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 86:673-680, 1994
21. Rosell R, Gomez-Codina J, Camps C, et al: A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 330:153-158, 1994